Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results intwo distinct transport activities

Citation
A. Rajgopal et al., Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results intwo distinct transport activities, AM J P-CELL, 281(5), 2001, pp. C1579-C1586
Citations number
43
Categorie Soggetti
Cell & Developmental Biology
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
ISSN journal
03636143 → ACNP
Volume
281
Issue
5
Year of publication
2001
Pages
C1579 - C1586
Database
ISI
SICI code
0363-6143(200111)281:5<C1579:EOTRFC>2.0.ZU;2-E
Abstract
Intestinal absorption of folates has been characterized as a facilitative p rocess with a low pH optimum. Studies with intestinal epithelial cells have suggested that this activity is mediated by the reduced folate carrier (RF C1). In this paper, we report on folate transport characteristics in an imm ortalized rat IEC-6 cell line that was found to exhibit the predominant inf lux activity for methotrexate (MTX) at pH 5.5 with a low level of activity at pH 7.4. Transfection of this cell line with an RFC1 construct resulted i n clones exhibiting increased MTX uptake at both the pHs and high folic aci d uptake only at the low pH. For the two clones with the highest level of t ransport activity, relative MTX influx at the two pHs was reversed. Moreove r, the low pH MTX influx activity ([ MTX](e) = 0.5 muM) was markedly inhibi ted by 20 muM folic acid while influx at neutral pH was not. Furthermore, i n the presence and absence of glucose at low pH, MTX and folic acid influx activity was inhibited by azide, while MTX influx at pH 7.4 was stimulated by azide in the absence of glucose but was unchanged in the presence of glu cose and azide. This was contrasted with the results of transfection of the same RFC1 construct into an L1210 murine leukemia cell line bearing a nonf unctional endogenous carrier. In this case, the activity expressed was only at pH 7.4. These data indicate that RFC1 can exhibit two distinct types of folate transport activities in intestinal cells that must depend on tissue -specific modulators.